VEGFA and glioblastoma: Another characteristic of glioblastoma is focal angiogenesis in the vicinity of areas of necrosis, and this has been rationale for preclinical and clinical testing of anti-VEGF therapy for recurrent and primary diagnosed glioblastoma.